DAR · Darling Ingredients Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.55B | $1.56B | $1.48B | $1.38B | - | $1.42B | $1.46B | $1.42B | - | $1.63B |
| Cost of Revenue | $1.15B | $1.18B | $1.14B | $1.07B | - | $1.11B | $1.13B | $1.12B | - | $1.24B |
| Gross Profit | $404.92M | $313.57M | $326.87M | $311.35M | - | $313.57M | $326.87M | $303.63M | - | $386.47M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $149.07M | $139.59M | $138.07M | $121.56M | - | $115.72M | $129.73M | $139.14M | - | $137.70M |
| Total Operating Expenses | $1.43B | $1.45B | $1.41B | $1.32B | - | $1.36B | $1.35B | $1.36B | - | $1.50B |
| D&A | $130.91M | $124.06M | $121.06M | $123.83M | - | $123.55M | $124.61M | $127.51M | - | $125.99M |
| Operating Income | $226.77M | $71.73M | $75.87M | $28.40M | - | $60.11M | $148.50M | $137.17M | - | $178.37M |
| Interest Expense | $54.12M | $66.85M | $51.87M | $57.97M | - | - | - | - | - | - |
| Income Tax | $38.63M | ($1.25M) | $4.07M | ($1.15M) | - | ($17.47M) | $774.0K | $3.91M | - | ($15.36M) |
| Net Income | $134.31M | $19.36M | $12.66M | ($26.16M) | - | $16.95M | $78.87M | $81.16M | - | $125.03M |
| EPS - Basic | $0.85 | $0.12 | $0.08 | ($0.16) | - | $0.11 | $0.49 | $0.51 | - | $0.78 |
| EPS - Diluted | $0.83 | $0.12 | $0.08 | ($0.16) | - | $0.11 | $0.49 | $0.50 | - | $0.77 |
Balance Sheet
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $116.02M | $91.49M | $94.58M | $81.47M | $75.97M | $114.78M | $121.59M | $145.47M | $126.50M | $118.98M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | $735.58M |
| Inventory | $577.57M | $622.32M | $605.33M | $595.41M | $576.84M | $617.85M | $627.69M | $687.49M | $758.74M | $822.76M |
| Accounts Payable | $356.21M | $374.80M | $365.74M | $348.48M | $348.70M | $331.69M | $349.52M | $343.39M | $425.59M | $394.75M |
| Current Assets | $1.65B | $1.50B | $1.50B | $1.45B | $1.44B | $1.50B | $1.51B | $1.62B | $1.86B | $1.84B |
| Total Assets | $10.64B | $10.45B | $10.27B | $10.03B | $10.07B | $10.57B | $10.62B | $10.94B | $11.06B | $10.81B |
| Current Liabilities | $1.04B | $1.01B | $996.70M | $1.04B | $1.04B | $1.06B | $963.06M | $967.29M | $998.14M | $1.03B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $5.70B | $5.68B | $5.58B | $5.50B | $5.61B | $5.94B | $6.08B | $6.26B | $6.37B | $6.34B |
| Stockholders' Equity | $4.88B | $4.69B | $4.61B | $4.45B | $4.38B | $4.55B | $4.46B | $4.59B | $4.61B | $4.38B |
| Retained Earnings | $4.21B | $4.02B | $4.00B | $3.99B | $4.01B | $3.91B | $3.89B | $3.81B | $3.73B | $3.65B |
Cash Flow
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $152.96M | - | - | $248.96M | - | - | - | $263.91M | - | - |
| Investing Cash Flow | ($288.73M) | - | - | ($50.66M) | - | - | - | ($290.96M) | - | - |
| Financing Cash Flow | $183.05M | - | - | ($185.23M) | - | - | - | $48.77M | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 26.1% | 20.0% | 22.1% | 22.6% | - | 22.1% | 22.5% | 21.4% | - | 23.8% |
| Operating margin | 14.6% | 4.6% | 5.1% | 2.1% | - | 4.2% | 10.2% | 9.7% | - | 11.0% |
| EBITDA margin | 23.1% | 12.5% | 13.3% | 11.0% | - | 12.9% | 18.8% | 18.6% | - | 18.7% |
| Net margin | 8.7% | 1.2% | 0.9% | -1.9% | - | 1.2% | 5.4% | 5.7% | - | 7.7% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 9.6% | 8.9% | 9.3% | 8.8% | - | 8.1% | 8.9% | 9.8% | - | 8.5% |
| Effective tax rate | 22.3% | -6.9% | 24.3% | - | - | - | 1.0% | 4.6% | - | -14.0% |
| Return on assets | 1.3% | 0.2% | 0.1% | -0.3% | - | 0.2% | 0.7% | 0.7% | - | 1.2% |
| Return on equity | 2.8% | 0.4% | 0.3% | -0.6% | - | 0.4% | 1.8% | 1.8% | - | 2.9% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.58 | 1.49 | 1.50 | 1.40 | 1.38 | 1.41 | 1.57 | 1.67 | 1.86 | 1.78 |
| Quick ratio | 1.03 | 0.87 | 0.89 | 0.83 | 0.83 | 0.83 | 0.91 | 0.96 | 1.10 | 0.99 |
| Cash ratio | 0.11 | 0.09 | 0.09 | 0.08 | 0.07 | 0.11 | 0.13 | 0.15 | 0.13 | 0.12 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 4.2x | 1.1x | 1.5x | 0.5x | - | - | - | - | - | - |
| Equity multiplier | 2.18 | 2.23 | 2.23 | 2.26 | 2.30 | 2.32 | 2.38 | 2.38 | 2.40 | 2.47 |
| Liabilities / Assets | 0.54 | 0.54 | 0.54 | 0.55 | 0.56 | 0.56 | 0.57 | 0.57 | 0.58 | 0.59 |
| Efficiency | ||||||||||
| Asset turnover | 0.15 | 0.15 | 0.14 | 0.14 | - | 0.13 | 0.14 | 0.13 | - | 0.15 |
| Inventory turnover | 1.98 | 1.89 | 1.88 | 1.80 | - | 1.79 | 1.80 | 1.62 | - | 1.51 |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | 165d |
| Days inventory outstanding | 184d | 193d | 195d | 203d | - | 203d | 203d | 225d | - | 242d |
| Days payable outstanding | 113d | 116d | 118d | 119d | - | 109d | 113d | 112d | - | 116d |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | 291d |
| Valuation | ||||||||||
| P / E | 77.9x | 267.6x | 476.5x | - | - | 343.3x | 75.0x | 93.0x | - | 67.8x |
| P / B | 2.1x | 1.1x | 1.3x | 1.1x | - | 1.3x | 1.3x | 1.6x | - | 1.9x |
| P / S | 6.7x | 3.3x | 4.1x | 3.6x | - | 4.3x | 4.1x | 5.3x | - | 5.2x |
| EV / EBITDA | 28.8x | 25.8x | 30.4x | 32.3x | - | 32.5x | 21.3x | 27.9x | - | 27.5x |
| Growth | ||||||||||
| Revenue growth (YoY) | 12.3% | 10.0% | 1.8% | -2.8% | - | -12.5% | -17.2% | -20.7% | - | -7.0% |
| Revenue CAGR (3y) | -4.7% | -3.6% | -3.5% | 0.3% | - | 6.2% | 6.7% | 10.7% | - | 24.1% |
| Revenue CAGR (5y) | 8.2% | 13.0% | 11.8% | 10.1% | - | 11.0% | 12.0% | 11.2% | - | 11.7% |
| Gross profit growth (YoY) | 30.1% | 0.0% | 0.0% | 2.5% | - | -18.9% | -17.9% | -28.4% | - | 2.7% |
| Operating income growth (YoY) | 698.5% | 19.3% | -48.9% | -79.3% | - | -66.3% | -58.4% | -46.4% | - | -33.5% |
| Net income growth (YoY) | - | 14.2% | -83.9% | - | - | -86.4% | -68.8% | -56.3% | - | -34.6% |
| EPS growth (YoY) | - | 9.1% | -83.7% | - | - | -85.7% | -68.4% | -56.1% | - | -34.2% |
| EPS CAGR (3y) | -10.0% | -53.2% | -59.8% | - | - | -50.0% | -25.2% | -17.8% | - | 8.1% |
| EPS CAGR (5y) | -1.6% | -27.8% | -27.2% | - | - | -6.0% | 25.1% | 35.4% | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 9.6% | 3.0% | 3.4% | -3.2% | -4.9% | 3.9% | 2.1% | 13.9% | 20.9% | 22.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-01-03.
Business segments
$6.14B totalFeed Ingredients$3.99B · 65.0%
Food Ingredients$1.55B · 25.2%
Fuel Ingredients$600.76M · 9.8%
Product / service
$5.84B totalFats$1.60B · 27.3%
Proteins$1.41B · 24.1%
Food Ingredients Productsand Services$1.25B · 21.5%
Bioenergy$600.76M · 10.3%
Used Cooking Oil$445.49M · 7.6%
Other Rendering$295.70M · 5.1%
Bakery$195.44M · 3.3%
Other Products And Services$48.01M · 0.8%
Geographic
$3.99B totalNorth America$3.04B · 76.2%
Europe$457.34M · 11.5%
South America$445.13M · 11.2%
CN$32.90M · 0.8%
Other Geographical Areas$15.30M · 0.4%
Peer comparison
Same SIC group: Fats & Oils
Comparing DARLING INGREDIENTS INC. against the 5 most active filers in the same SIC group.